Quality of life in patients with skull base tumors: current status and future challenges
- PMID: 20592852
- PMCID: PMC2853066
- DOI: 10.1055/s-0029-1242979
Quality of life in patients with skull base tumors: current status and future challenges
Abstract
In selection of the right treatment for a specific patient, the surgeon should consider not only the best approach to remove a tumor but also the impact of treatment on the quality of life (QOL) of the patient. Procedures involving extirpation of skull base tumors may be associated with high morbidity. It is therefore important to study patients with skull base neoplasms, because survival differences between various treatment modalities may be small, yet larger differences are expected regarding morbidity. The overall QOL in the majority of patients after skull base tumor resection can be classified as "good," with significant improvement taking place within 12 months following surgery. Patients with carcinomas, acoustic schwannoma, or Cushing's disease suffer from more significant deterioration in their QOL after any intervention. Data retrieved from disease-specific questionnaires revealed that the financial and emotional domains have the worse impact on patients QOL. Old age, malignancy, comorbidity, radiotherapy, and extensive surgery were found to be also negative prognostic factors for QOL. Pain control regimens, antidepressants, and other psychological modalities, including group support, can improve QOL measures in these patients. It is critical that surgeons understand that they cannot assess their patients' perspectives on QOL correctly without asking them. For adequate assessment, validated disease-specific instruments addressing multiple domains of QOL should be utilized.
Keywords: Quality of life; cancer; cranial base; craniofacial; neurosurgery.
References
-
- Gil Z, Abergel A, Spektor S, et al. Quality of life following surgery for anterior skull base tumors. Arch Otolaryngol Head Neck Surg. 2003;129:1303–1309. - PubMed
-
- Gil Z, Abergel A, Spektor S, Shabtai E, Khafif A, Fliss D M. Development of a cancer-specific anterior skull base quality-of-life questionnaire. J Neurosurg. 2004;100:813–819. - PubMed
-
- Gil Z, Patel S G, Singh B, et al. International Collaborative Study Group Analysis of prognostic factors in 146 patients with anterior skull base sarcoma: an international collaborative study. Cancer. 2007;110:1033–1041. - PubMed
-
- Langendijk H, Aaronson N K, de Jong J M, ten Velde G P, Muller M J, Wouters M. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol. 2000;55:19–25. - PubMed
-
- Movsas B. Exploring the role of the radioprotector amifostine in locally advanced non-small cell lung cancer: Radiation Therapy Oncology Group trial 98-01. Semin Radiat Oncol. 2002;12(1, Suppl 1):40–45. - PubMed
LinkOut - more resources
Full Text Sources
Medical
